Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione is a synthetic small molecule belonging to the indole family. It has a molecular formula of C18H17NO4 and a molecular weight of approximately 311.3 g/mol[1][2][3][5]. This compound is classified as an indolequinone derivative and is primarily studied as an experimental tool compound rather than for therapeutic use. Notably, it has been used in biochemical research as a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 (NQO1), an enzyme involved in cellular redox regulation[4][9]. The inhibition occurs via covalent modification after metabolic activation by NQO1. There are no approved medical indications or clinical trials for this compound; its primary application remains in laboratory studies investigating NQO1 function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-methoxy-1,2-dimethyl-3-(phenoxymethyl)indole-4,7-dione.